Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
salicylic acid ointment 10%
- Development stage
- Unknown
- Lead developer
- Dr. Kulich Pharma
- Modality
- Small Molecules
- Administration
- Topical
01
Overview
Salicylic acid ointment 10% is a topical keratolytic preparation used to treat various hyperkeratotic and scaling skin conditions. Manufactured by **Dr. Kulich Pharma** as a compounded medicinal product, it works by increasing skin moisture and dissolving the intercellular substance that causes skin cells to adhere, thereby facilitating the shedding of the stratum corneum. This concentration is typically indicated for localized treatment of thick plaques in conditions like psoriasis, ichthyosis, or for the removal of warts and calluses.
- Other names
- Acidi salicylici unguentum 10%salicylic acid 10% ointment
02
Targets
SULT2B1b (Sulfotransferase family 2B member 1 (SULT2B1))COXStratum corneum intercellular lipid matrix
Beyond the preview
Go deeper on salicylic acid ointment 10%.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on salicylic acid ointment 10%.